The oncogenic potential of human papillomaviruses: A review on the role of host genetics and environmental cofactors

British Journal of Dermatology

Volumn 157, Issue 2, 2007, Pages 228-241

  Madkan, V K ^a   Cook Norris, R H ^b   Steadman, M C ^c   Arora, A ^a   Mendoza, N ^d   Tyring, S K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

Environmental cofactors; Human papillomavirus; Oncogene; Review

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIBODY; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; GLYCOPROTEIN E2; INTERLEUKIN 10; L1 ANTIBODY; PROTEIN P53; RETINOIC ACID RECEPTOR; TOBACCO SMOKE; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ANUS CANCER; BACTERIUM; CARCINOGENESIS; CARCINOGENICITY; CLINICAL TRIAL; DIET; ENVIRONMENTAL FACTOR; ESOPHAGUS CANCER; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; IONIZING RADIATION; LARYNX CANCER; OBESITY; PATHOGENESIS; PENIS CANCER; PRIORITY JOURNAL; PUVA; REVIEW; SKIN CANCER; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CANCER; VERRUCA VULGARIS; VIRION; VIRUS; VIRUS INFECTION; VULVA CANCER; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PHENOLS; RISK FACTORS;

EID: 34447559874     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07961.x     Document Type: Review

References (132)

1. Pfister H. Chapter 8. Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003 31 : 52 6.
2. Jablonska S, Millewski B. Zur Kenntnis der Epidermodysplasia verruciformis Lewandowsky-Lutz. Dermatologica 1957 111 : 1 22.
3. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995 131 : 1312 18.
4. Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005 32 (Suppl. 1 1 6.
5. Cheah PL, Looi NM. Biology and pathological associations of the human papillomaviruses: a review. Malays J Pathol 1998 20 : 1 10.
6. Muñoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
7. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006 110 : 525 41.
8. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 1988 48 : 3780 6.
9. Orth G, Jablonska S, Jarzabek-Chorzelska M et al. Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 1979 39 : 1074 82.
10. Wang SS, Hildesheim A. Chapter 5. Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr 2003 31 : 35 40.
11. Schmidt MT, Olejnik AK, Gozdzicka-Jozefiak A. The HPV16 E2 transcriptional regulator mode of action depends on the physical state of the viral genome. Acta Biochim Pol 2005 52 : 823 32.
12. Romanczuk H, Howley PM. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci USA 1992 89 : 3159 63.
13. Bellanger S, Blachon S, Mechali F et al. High-risk but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle 2005 4 : 1608 15.
14. Evans MF, Koreth J, Bakkenist CJ et al. Allelic deletion at 11q23.3-q25 is an early event in cervical neoplasia. Oncogene 1998 16 : 2557 64.
15. Bartsch D, Boye B, Baust C et al. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 1992 11 : 2283 91.
16. Zeng M, Kumar A, Meng G et al. Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator. J Biol Chem 2002 277 : 45611 18.
17. Borger DR, Mi Y, Geslani G et al. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta. Virology 2000 270 : 397 407.
18. Storey A, Thomas M, Kalita A et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998 393 : 229 34.
19. Koushik A, Ghosh A, Duarte-Franco E et al. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detect Prev 2005 29 : 307 16.
20. Andersson S, Rylander E, Strand A et al. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br J Cancer 2001 85 : 1153 6.
21. Jee SH, Won SY, Yun JE et al. Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Int J Gynaecol Obstet 2004 85 : 301 8.
22. Madeleine MM, Shera K, Schwartz SM et al. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer. Cancer Epidemiol Biomarkers Prev 2000 9 : 225 7.
23. de Oliveira WR, Rady PL, Grady J et al. Association of p53 arginine polymorphism with skin cancer. Int J Dermatol 2004 43 : 489 93.
24. Marshall SE, Bordea C, Wojnarowska F et al. p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. Transplantation 2000 69 : 994 6.
25. Bastiaens MT, Struyk L, Tjong-A-Hung SP et al. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening? Mol Carcinog 2001 30 : 56 61.
26. de Oliveira WR, Rady PL, Grady J et al. Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis. J Am Acad Dermatol 2003 49 : 639 43.
27. Stanczuk GA, Sibanda EN, Perrey C et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer 2001 94 : 792 4.
28. Zoodsma M, Nolte IM, Schipper M et al. Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum Genet 2005 116 : 247 54.
29. Piyathilake CJ, Macaluso M, Johanning GL et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 2000 20 : 1751 7.
30. Gerhard DS, Nguyen LT, Zhang ZY et al. A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol 2003 90 : 560 5.
31. Purdie KJ, Surentheran T, Sterling JC et al. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol 2005 125 : 98 107.
32. Shamanin V, zur Hausen H, Lavergne D et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996 88 : 802 11.
33. Ramoz N, Rueda LA, Bouadjar B et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002 32 : 579 81.
34. Harima Y, Sawada S, Nagata K et al. Polymorphism of the WAF1 gene is related to susceptibility to cervical cancer in Japanese women. Int J Mol Med 2001 7 : 261 4.
35. Bahl R, Arora S, Nath N et al. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer. Oncogene 2000 19 : 323 8.
36. Hachiya T, Kuriaki Y, Ueoka Y et al. WAF1 genotype and endometrial cancer susceptibility. Gynecol Oncol 1999 72 : 187 92.
37. Shi Y, Zou M, Farid NR, al-Sedairy ST. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas. Br J Cancer 1996 74 : 1336 41.
38. Gao X, Chen YQ, Wu N et al. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. Oncogene 1995 11 : 1395 8.
39. Bonagura VR, Siegal FP, Abramson AL et al. Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis. Clin Diagn Lab Immunol 1994 1 : 357 60.
40. Beskow AH, Gyllensten UB. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 2002 101 : 526 31.
41. Bonagura VR, Vambutas A, DeVoti JA et al. HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Hum Immunol 2004 65 : 773 82.
42. Cuzick J, Terry G, Ho L et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 2000 82 : 1348 52.
43. Beskow AH, Moberg M, Gyllensten UB. HLA class II allele control of HPV load in carcinoma in situ of the cervix uteri. Int J Cancer 2005 10 : 510 14.
44. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002 89 : 229 40.
45. Sastre-Garau X, Loste MN, Vincent-Salomon A et al. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 1996 69 : 159 64.
46. Koskinen WJ, Partanen J, Vaheri A, Aaltonen LM. HLA-DRB1, -DQB1 alleles in head and neck carcinoma patients. Tissue Antigens 2006 67 : 237 40.
47. Oka A, Hayashi H, Tomizawa M et al. Localization of a non-melanoma skin cancer susceptibility region within the major histocompatibility complex by association analysis using microsatellite markers. Tissue Antigens 2003 61 : 203 10.
48. Dunn DS, Inoko H, Kulski JK. The association between non-melanoma skin cancer and a young dimorphic Alu element within the major histocompatibility complex class I genomic region. Tissue Antigens 2006 68 : 127 34.
49. Cerimele D, Contu L, Carcassi C et al. HLA and multiple skin carcinomas. Dermatologica 1988 176 : 176 81.
50. Czarnecki D, Watkins F, Leahy S et al. Skin cancers and HLA frequencies in renal transplant recipients. Dermatology 1992 185 : 9 11.
51. Czarnecki D, Tait B, Nicholson I, Lewis A. Multiple non-melanoma skin cancer: evidence that different MHC genes are associated with different cancers. Dermatology 1994 188 : 88 90.
52. Maciag PC, Villa LL. Genetic susceptibility to HPV infection and cervical cancer. Braz J Med Biol Res 1999 32 : 915 22.
53. Laga M, Icenogle JP, Marselha R et al. Genital papillomavirus infection and cervical dysplasia: opportunistic complications of HIV infection. Int J Cancer 1992 50 : 45 8.
54. Patel HS, Silver AR, Northhover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis 2005 16 : 1 5.
55. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Phys 1999 111 : 581 7.
56. Braun L, Durst M, Mikumo R et al. Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the role of papillomavirus infection. Mol Carcinog 1992 6 : 100 11.
57. Kyo S, Inohue M, Hayasaka N et al. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 1994 200 : 130 9.
58. Soto U, Das BC, Lengert M et al. Conversion of HPV 18 positive non-tumorigenic HeLa fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 1999 111 : 3187 98.
59. Rosl F, Lengert M, Albrecht J et al. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J Virol 1994 68 : 2142 50.
60. Kleine K, Konig G, Kreuzer J et al. The effect of JE (MNP-1) gene, which encodes monocyte chemoattractant protein-1, on the growth of HeLa cells and derived somatic-cell hybrids in nude mice. Mol Carcinog 1995 14 : 179 89.
61. de Villiers EM, Ruhland A. Do specific human papillomavirus types cause psoriasis? Arch Dermatol 2001 137 : 384.
62. Ruhland A, de Villiers EM. Opposite regulation of the HPV 20-URR and HPV 27-URR promoters by ultraviolet irradiation and cytokines. Int J Cancer 2001 91 : 828 34.
63. Picinni A, Storey A, Romanos M, Banks L. Regulation of human papillomavirus type 16 DNA replication by E2, glucocorticoid hormone and epidermal growth factor. J Gen Virol 1997 78 : 1963 70.
64. Gloss B, Bernhard HU, Seedorf K, Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 1987 6 : 3735 43.
65. Pater MM, Hughes GA, Hyslop DE et al. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature 1988 335 : 832 5.
66. Pater MM, Pater A. RU486 inhibits glucocorticoid hormone-dependent oncogenesis by human papillomavirus type 16 DNA. Virology 1991 183 : 799 802.
67. Bromberg-White JL, Meyers C. Comparison of the basal and glucocorticoid-inducible activities of the upstream regulatory regions of HPV18 and HPV31 in multiple epithelial cell lines. Virology 2003 306 : 197 202.
68. Rocha-Zavaleta L, Jordan D, Pepper S et al. Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia. Br J Cancer 1997 75 : 1144 50.
69. Schwarz E, Freese UK, Gissmann L et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985 314 : 111 14.
70. Corona Gutierrez CM, Tinoco A, Navaro T et al. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus. Hum Gene Ther 2004 15 : 421 31.
71. Bavinck JN, Gissmann L, Claas FH et al. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients. J Immunol 1993 151 : 1579 86.
72. Yang R, Wheeler CM, Chen X et al. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer. J Virol 2005 79 : 6741 50.
73. Ahdieh L, Muñoz A, Vlahov D et al. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 2000 151 : 1148 57.
74. Ellerbrock TV, Chiasson MA, Bush TJ et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000 283 : 1031 7.
75. Tornesello ML, Buonaguro FM, Beth-Giraldo E, Giraldo G. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 1993 36 : 57 64.
76. Arany I, Evans T, Tyring SK. Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals. Sex Transm Infect 1998 74 : 349 53.
77. Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 1993 27 : 133 45.
78. Dolei A, Curreli S, Marongiu P et al. Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. J Gen Virol 1999 80 : 2937 44.
79. Maurer TA, Christian KV, Kerschmann RL et al. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol 1997 133 : 577 83.
80. Masini C, Fuchs PG, Gabrielli F et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003 139 : 890 4.
81. Silins I, Wang Z, Avall-Lundqvist E et al. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Virol 1999 80 : 2931 6.
82. Castellsague X, Bosch FX, Muñoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002 89 : 191 9.
83. Jackson S, Harwood C, Thomas M et al. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000 14 : 3065 73.
84. Jackson S, Ghali L, Harwood C, Storey A. Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus. Br J Cancer 2002 87 : 319 23.
85. Purdie KJ, Pennington J, Proby CM et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J 1999 18 : 5359 69.
86. Giampieri S, Garcia-Escudero R, Green J, Storey A. Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation. Oncogene 2004 23 : 5864 70.
87. Giampieri S, Storey A. Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18. Br J Cancer 2004 90 : 2203 9.
88. Akgul B, Lemme W, Garcia-Escudero R et al. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch Virol 2005 150 : 145 51.
89. Wolf P, Seidl H, Back B et al. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A. Arch Dermatol 2004 140 : 317 24.
90. Harwood CA, Spink PJ, Surentheran T et al. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers. J Invest Dermatol 1998 111 : 123 7.
91. Lindeberg H, Elbrond O. Malignant tumours in patients with a history of multiple laryngeal papillomas: the significance of irradiation. Clin Otolaryngol 1991 16 : 149 51.
92. Jablonska S, Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol 1994 186 : 157 75.
93. Cortes-Franco R, Tyring SK, Vega E et al. Divergent clinical course of epidermodysplasia verruciformis in siblings. Int J Dermatol 1997 36 : 442 5.
94. Rous P, Friedewald WF. The effect of chemical carcinogens on virus-induced rabbit papillomas. J Exp Med 1944 79 : 511 38.
95. Deacon JM, Evans CD, Yule R et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000 83 : 1565 72.
96. Kruger-Kjaer S, van den Brule AJ, Svare EI et al. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer 1998 76 : 613 19.
97. Hildesheim A, Herrero R, Castle PE et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 2001 84 : 1219 26.
98. Schiffman MH, Bauer HM, Hoover RN et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993 85 : 958 64.
99. Daling JR, Madeleine MM, Johnson LG. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004 101 : 270 80.
100. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst 1997 89 : 868 73.
101. Sun H, Gong Y, Wang Q, Chen J. Malignant transformation of HPV-18 immortalized human bronchial epithelial cells induced by tobacco-specific nitrosamine NNK. Wei Sheng Yan Jiu 1999 28 : 95 6.
102. Melikian AA, Wang X, Waggoner S et al. Comparative response of normal and of human papillomavirus-16 immortalized human epithelial cervical cells to benzo[a]pyrene. Oncol Rep 1999 6 : 1371 6.
103. Poppe WA, Ide PS, Drijkoningen MP et al. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 1995 39 : 34 8.
104. Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with p53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 2002 97 : 649 53.
105. D'Costa J, Saranath D, Dehia P et al. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998 34 : 413 20.
106. Al-Bakkal G, Ficarra G, McNeill K et al. Human papilloma virus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 87 : 197 208.
107. Ibrahim SO, Bertelsen B, Kalvenes MB et al. Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS 1998 106 : 959 69.
108. Rohatgi N, Kaur J, Srivastava A, Ralhan R. Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia. Oral Oncol 2005 41 : 806 20.
109. Young SK, Min KW. In situ DNA hybridization analysis of oral papillomas, leukoplakias, and carcinomas for human papillomavirus. Oral Surg Oral Med Oral Pathol 1991 71 : 726 9.
110. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 91 : 622 35.
111. Hildesheim A, Mann V, Brinton LA et al. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer 1991 49 : 335 40.
112. Moreno V, Bosch FX, Muñoz N et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002 359 : 1085 92.
113. Smith JS, Herrero R, Bosetti C et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002 94 : 1604 13.
114. Daling JR, Madeleine MM, McKnight B et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996 5 : 541 8.
115. Smith JS, Muñoz N, Herrero R et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002 185 : 324 31.
116. Muñoz N, Franceschi S, Bosetti C et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 2002 359 : 1093 101.
117. DiPaolo JA, Woodworth CD, Coutlee F et al. Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus immortalized cervical keratinocytes. Int J Cancer 1998 76 : 865 71.
118. Peters RK, Thomas D, Hagan DG et al. Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst 1986 77 : 1063 77.
119. Tran-Thanh D, Provencher D, Koushik A et al. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 2003 188 : 129 34.
120. Tamim H, Finan RR, Sharida HE et al. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 2002 43 : 277 81.
121. Wallin KL, Wiklund F, Luostarinen T et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 2002 101 : 371 4.
122. Anttila T, Saikku P, Koskela P et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001 285 : 47 51.
123. de Sanjose S, Muñoz N, Bosch FX et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994 56 : 358 63.
124. Koskela P, Anttila T, Bjorge T et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000 85 : 35 9.
125. Castle PE, Escoffery C, Schachter J et al. Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis 2003 30 : 575 80.
126. Goodman MT, McDuffie K, Hernandez B et al. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 2001 10 : 1275 80.
127. Garcia-Closas R, Castellsague X, Bosch X, Gonzalez CA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005 117 : 629 37.
128. Lacey JV Jr., Swanson CA, Brinton LA et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003 98 : 814 21.
129. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003 348 : 1625 38.
130. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979 32 : 563 76.
131. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994 30 : 344 50.
132. Wolk A, Gridley G, Svensson M et al. A prospective study of obesity and cancer risk. Cancer Causes Control 2001 12 : 13 21.